Patents by Inventor Yong Ha Chi

Yong Ha Chi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY OF DONEPEZIL AND TADALAFIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR COGNITIVE IMPAIRMENT
    Publication number: 20230405004
    Abstract: The present invention relates to a combination therapy of donepezil and tadalafil for the prevention, treatment or improvement of Alzheimer's disease or cognitive impairment. The combined administration of donepezil and tadalafil according to the present invention has a superior effect on improving Alzheimer's disease or cognitive impairment as compared to single administration of donepezil, which is able to be effectively used as a therapeutic therapy or a complex agent for Alzheimer's disease or cognitive impairment.
    Type: Application
    Filed: November 5, 2021
    Publication date: December 21, 2023
    Applicant: NEURORIVE INC
    Inventors: Sukchan LEE, Yong Ha CHI, Hyun-Hee RYU, Miso JEONG
  • COMBINATION THERAPY OF DONEPEZIL AND SILDENAFIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR COGNITIVE IMPAIRMENT
    Publication number: 20230398106
    Abstract: The present invention relates to a combination therapy of donepezil and sildenafil for the prevention, treatment or improvement of Alzheimer's disease or cognitive impairment. The combined administration of donepezil and sildenafil according to the present invention has a superior effect on improving Alzheimer's disease or cognitive impairment as compared to single administration of donepezil, which is able to be effectively used as a therapeutic therapy or a complex agent for Alzheimer's disease or cognitive impairment.
    Type: Application
    Filed: November 5, 2021
    Publication date: December 14, 2023
    Applicant: NEURORIVE INC
    Inventors: Sukchan LEE, Yong Ha CHI, Hyun-Hee RYU, Miso JEONG
  • CYCLOSERINE AND PENTOXIFYLLINE COMBINATION THERAPY FOR TREATMENT OF DEPRESSION
    Publication number: 20230165866
    Abstract: The present invention provides to a composite composition for preventing or treating depression comprising (i) cycloserine or a pharmaceutically acceptable salt thereof; and (ii) pentoxifylline or a pharmaceutically acceptable salt thereof. The composite composition may be effectively used as an antidepressant.
    Type: Application
    Filed: May 7, 2021
    Publication date: June 1, 2023
    Applicant: NEURORIVE INC
    Inventors: Sukchan LEE, Yong Ha CHI, Dong Cheol JIANG, Hyeonjoo HWANG
  • COMBINATION THERAPY OF CYCLOSERINE AND LITHIUM FOR THE TREATMENT OF DEPRESSION
    Publication number: 20220387481
    Abstract: The present invention relates to a combination therapy of cycloserine and lithium for the prevention or treatment of depression. The combined administration of cycloserine and lithium according to the present invention has a remarkably excellent effect of preventing or treating depression compared to each single administration, thereby being effectively utilized as a combination therapy for antidepressants.
    Type: Application
    Filed: November 27, 2020
    Publication date: December 8, 2022
    Applicant: NEURORIVE INC
    Inventors: Sukchan LEE, Yong Ha CHI, Dong Cheol JANG, Gibeom KWON
  • Compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same
    Patent number: 9227955
    Abstract: Disclosed are an anti-angiogenic compound, represented by Chemical Formula I, or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutically acceptable composition including the same. Because the compound of Chemical Formula I potently suppresses the angiogenesis, the compound of Chemical Formula I is applicable to the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, and available as an anti-angiogenic agent.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: January 5, 2016
    Assignee: Boryung Pharmaceutical Co., Ltd.
    Inventors: Ji Han Kim, Je Hak Kim, Joon Kwang Lee, Hahn-Sun Jung, Nam Seok Han, Yong Park, Seung-Hoon Kang, Hee Jin Jeong, Kyung-Tae Lee, Hye Eun Choi, Yong Ha Chi, Joo Han Lee, Soo Heui Paik
  • Novel Compound Having Angiogenesis Inhibitory Activity, Method for Preparing Same, and Pharmaceutical Composition Comprising Same
    Publication number: 20140256711
    Abstract: Disclosed are an anti-angiogenic compound, represented by Chemical Formula I, or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutically acceptable composition including the same. Because the compound of Chemical Formula I potently suppresses the angiogenesis, the compound of Chemical Formula I is applicable to the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, and available as an anti-angiogenic agent.
    Type: Application
    Filed: July 27, 2012
    Publication date: September 11, 2014
    Applicant: Boryung Pharmaceutical Co., Ltd.
    Inventors: Ji Han Kim, Je Hak Kim, Joon Kwang Lee, Hahn-Sun Jung, Nam Seok Han, Yong Park, Seung-Hoon Kang, Hee Jin Jeong, Kyung-Tae Lee, Hye Eun Choi, Yong Ha Chi, Joo Han Lee, Soo Heui Paik
  • Antihypertensive pharmaceutical composition
    Patent number: 8765776
    Abstract: Provided is an antihypertensive pharmaceutical composition containing Fimasartan, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as an angiotensin II receptor blocker, and Amlodipine, an isomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as a calcium channel blocker.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: July 1, 2014
    Assignee: Boryung Pharmaceutical Co., Ltd.
    Inventors: Seung Ho Kim, Ji Han Kim, Je Hak Kim, Kyung Wan Nam, Yong Ha Chi, Joo Han Lee, Soo Heui Paik, So Jeong Yi, Tae Eun Kim, Seo Hyun Yoon, Joo Youn Cho, Sang Goo Shin, In Jin Jang, Kyung Sang Yu
  • ANTIHYPERTENSIVE PHARMACEUTICAL COMPOSITION
    Publication number: 20120264772
    Abstract: Provided is an antihypertensive pharmaceutical composition containing Fimasartan, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as an angiotensin II receptor blocker, and Amlodipine, an isomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as a calcium channel blocker.
    Type: Application
    Filed: August 8, 2011
    Publication date: October 18, 2012
    Inventors: Seung Ho Kim, Ji Han Kim, Je Hak Kim, Kyung Wan Nam, Yong Ha Chi, Joo Han Lee, Soo Heui Paik, So Jeong Yi, Tae Eun Kim, Seo Hyun Yoon, Joo Youn Cho, Sang Goo Shin, In Jin Jang, Kyung Sang Yu